Calvert Formula, Mawer (m)

GFR Mawer

Loading...

GFR Mawer

yrs
mg/ml*min

References

  1. Jennifer S Lees. Accuracy of glomerular filtration rate estimates among patients with cancer.. British journal of cancer, 2025
  2. Stéphanie Gaillard. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025
  3. NA. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. Kidney international, 2024
  4. A. Horiike. Adjustment of creatinine (Cr) to avoid severe thrombocytopenia of carboplatin (C) plus gemcitabine (G) in non-small cell lung cancer (NSCLC).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
  5. T. Oguri. 1545PCARBOPLATIN DOSING WITH THE CALVERT FORMULA FOR ADULT JAPANESE PATIENTS WITH RENAL INSUFFICIENCY.. Annals of oncology : official journal of the European Society for Medical Oncology, 2014
  6. R. Cathomas. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.. Annals of oncology : official journal of the European Society for Medical Oncology, 2014
  7. M. Okera. The effect of Cockcroft-Gault (CG) measurement of GFR on carboplatin dosage in ovarian cancer patients compared with Cr51-EDTA.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011
  8. A H Calvert. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989